In this issue:
Hospitalisations and intestinal resections for IBD since introduction of anti-TNFs
Efficacy and safety of oral JAK inhibitors for IBD
Effectiveness, safety and therapeutic monitoring of thioguanine for IBD
Efficacy and safety of adalimumab by disease duration
Autologous adipose tissue injections into perianal fistulae in CD
Low meat diet failed to reduce CD flares
Cancer and mortality in paediatriconset IBD
First year of life, not neonatal, events affect later IBD risk
Please login below to download this issue (PDF)